163 related articles for article (PubMed ID: 10764160)
1. Evidence against a direct cytotoxic effect of alpha interferon and zidovudine in HTLV-I associated adult T cell leukemia/lymphoma.
Bazarbachi A; Nasr R; El-Sabban ME; Mahé A; Mahieux R; Gessain A; Darwiche N; Dbaibo G; Kersual J; Zermati Y; Dianoux L; Chelbi-Alix MK; de Thé H; Hermine O
Leukemia; 2000 Apr; 14(4):716-21. PubMed ID: 10764160
[TBL] [Abstract][Full Text] [Related]
2. Interferon-α (IFN-α) suppresses HTLV-1 gene expression and cell cycling, while IFN-α combined with zidovudine induces p53 signaling and apoptosis in HTLV-1-infected cells.
Kinpara S; Kijiyama M; Takamori A; Hasegawa A; Sasada A; Masuda T; Tanaka Y; Utsunomiya A; Kannagi M
Retrovirology; 2013 May; 10():52. PubMed ID: 23688327
[TBL] [Abstract][Full Text] [Related]
3. Thymoquinone synergizes with arsenic and interferon alpha to target human T-cell leukemia/lymphoma.
Houssein M; Fatfat M; Habli Z; Ghazal N; Moodad S; Khalife H; Khalil M; Gali-Muhtasib H
Life Sci; 2020 Jun; 251():117639. PubMed ID: 32272181
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells.
Bazarbachi A; El-Sabban ME; Nasr R; Quignon F; Awaraji C; Kersual J; Dianoux L; Zermati Y; Haidar JH; Hermine O; de Thé H
Blood; 1999 Jan; 93(1):278-83. PubMed ID: 9864171
[TBL] [Abstract][Full Text] [Related]
5. Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma.
Toomey NL; Deyev VV; Wood C; Boise LH; Scott D; Liu LH; Cabral L; Podack ER; Barber GN; Harrington WJ
Oncogene; 2001 Oct; 20(48):7029-40. PubMed ID: 11704827
[TBL] [Abstract][Full Text] [Related]
6. Zidovudine and interferon-alpha treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran.
Kchour G; Makhoul NJ; Mahmoudi M; Kooshyar MM; Shirdel A; Rastin M; Rafatpanah H; Tarhini M; Zalloua PA; Hermine O; Farid R; Bazarbachi A
Leuk Lymphoma; 2007 Feb; 48(2):330-6. PubMed ID: 17325893
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro treatment of HTLV-1 and HTLV-2 infected cells with arsenic trioxide and interferon-alpha.
Mahieux R; Hermine O
Leuk Lymphoma; 2005 Mar; 46(3):347-55. PubMed ID: 15621824
[TBL] [Abstract][Full Text] [Related]
8. Long-term clinical remission maintained after cessation of zidovudine and interferon-α therapy in chronic adult T-cell leukemia/lymphoma.
Cook LB; Rowan AG; Demontis MA; Sagawe S; Gillet NA; Melamed A; Greiller C; Witkover A; Bangham CRM; Taylor GP
Int J Hematol; 2018 Mar; 107(3):378-382. PubMed ID: 29090417
[TBL] [Abstract][Full Text] [Related]
9. Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives.
Bazarbachi A; Hermine O
Virus Res; 2001 Oct; 78(1-2):79-92. PubMed ID: 11520582
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide and the growth of human T-cell leukemia virus type I infected T-cell lines.
Ishitsuka K; Hanada S; Uozumi K; Utsunomiya A; Arima T
Leuk Lymphoma; 2000 May; 37(5-6):649-55. PubMed ID: 11042529
[TBL] [Abstract][Full Text] [Related]
11. Zidovudine and Interferon Alfa based regimens for the treatment of adult T-cell leukemia/lymphoma (ATLL): a systematic review and meta-analysis.
Shafiee A; Seighali N; Taherzadeh-Ghahfarokhi N; Mardi S; Shojaeian S; Shadabi S; Hasani M; Haghi S; Mozhgani SH
Virol J; 2023 Jun; 20(1):118. PubMed ID: 37287047
[TBL] [Abstract][Full Text] [Related]
12. Suppression of Type I Interferon Production by Human T-Cell Leukemia Virus Type 1 Oncoprotein Tax through Inhibition of IRF3 Phosphorylation.
Yuen CK; Chan CP; Fung SY; Wang PH; Wong WM; Tang HV; Yuen KS; Chan CP; Jin DY; Kok KH
J Virol; 2016 Apr; 90(8):3902-3912. PubMed ID: 26819312
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of mammalian target of rapamycin signaling by everolimus induces senescence in adult T-cell leukemia/lymphoma and apoptosis in peripheral T-cell lymphomas.
Darwiche N; Sinjab A; Abou-Lteif G; Chedid MB; Hermine O; Dbaibo G; Bazarbachi A
Int J Cancer; 2011 Aug; 129(4):993-1004. PubMed ID: 21064094
[TBL] [Abstract][Full Text] [Related]
14. Overview of Targeted Therapies for Adult T-Cell Leukemia/Lymphoma.
Nasr R; Marçais A; Hermine O; Bazarbachi A
Methods Mol Biol; 2017; 1582():197-216. PubMed ID: 28357672
[TBL] [Abstract][Full Text] [Related]
15. A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma.
Hermine O; Allard I; Lévy V; Arnulf B; Gessain A; Bazarbachi A;
Hematol J; 2002; 3(6):276-82. PubMed ID: 12522449
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes.
Bazarbachi A; Plumelle Y; Carlos Ramos J; Tortevoye P; Otrock Z; Taylor G; Gessain A; Harrington W; Panelatti G; Hermine O
J Clin Oncol; 2010 Sep; 28(27):4177-83. PubMed ID: 20585095
[TBL] [Abstract][Full Text] [Related]
17. Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells.
Mori N; Yamada Y; Ikeda S; Yamasaki Y; Tsukasaki K; Tanaka Y; Tomonaga M; Yamamoto N; Fujii M
Blood; 2002 Sep; 100(5):1828-34. PubMed ID: 12176906
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid dramatically enhances the arsenic trioxide-induced cell cycle arrest and apoptosis in retinoic acid receptor alpha-positive human T-cell lymphotropic virus type-I-transformed cells.
Darwiche N; El-Sabban M; Bazzi R; Nasr R; Al-Hashimi S; Hermine O; de Thé H; Bazarbachi A
Hematol J; 2001; 2(2):127-35. PubMed ID: 11424005
[TBL] [Abstract][Full Text] [Related]
19. Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL).
Kchour G; Tarhini M; Kooshyar MM; El Hajj H; Wattel E; Mahmoudi M; Hatoum H; Rahimi H; Maleki M; Rafatpanah H; Rezaee SA; Yazdi MT; Shirdel A; de Thé H; Hermine O; Farid R; Bazarbachi A
Blood; 2009 Jun; 113(26):6528-32. PubMed ID: 19411628
[TBL] [Abstract][Full Text] [Related]
20. Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemia.
Mone A; Puhalla S; Whitman S; Baiocchi RA; Cruz J; Vukosavljevic T; Banks A; Eisenbeis CF; Byrd JC; Caligiuri MA; Porcu P
Blood; 2005 Nov; 106(10):3380-2. PubMed ID: 16076875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]